Atricure Inc. Stock
Atricure Inc. Stock
With 13 Buy predictions and not the single Sell prediction the community is currently very high on Atricure Inc..
However, we have a potential of -29.41% for Atricure Inc. as the target price of 42 € is below the current price of 59.5 €.
Pros and Cons of Atricure Inc. in the next few years
Pros
?
C******** o* t** e**********
?
M***** P*******
?
G***** c******* t* c**********
Cons
?
B****
?
S********** s********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Atricure Inc. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Atricure Inc. | - | - | - | - | - | - | - |
Orasure Tech | -3.180% | -5.752% | -14.800% | -5.752% | -42.819% | -45.427% | -41.708% |
scPharmaceuticals | 7.020% | 11.585% | -12.857% | -61.270% | -36.348% | -20.087% | - |
SI-BONE Inc | -0.810% | 0.820% | -8.209% | -46.522% | -35.263% | -49.590% | - |
Comments
AtriCure, Inc. (NASDAQ: ATRC) had its price target lowered by analysts at JPMorgan Chase & Co. from $42.00 to $34.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for ATRC provided by MarketBeat
AtriCure, Inc. (NASDAQ: ATRC) had its price target lowered by analysts at Needham & Company LLC from $46.00 to $40.00. They now have a "buy" rating on the stock.
Show more
Ratings data for ATRC provided by MarketBeat
AtriCure, Inc. (NASDAQ: ATRC) was upgraded by analysts at Oppenheimer Holdings Inc. from a "market perform" rating to an "outperform" rating. They now have a $32.00 price target on the stock.
Show more
Ratings data for ATRC provided by MarketBeat